Evidence map›Paper›PMID 38502903›Full record

ArticleAmerican journal of respiratory cell and molecular biology2024

Cell-Corpse Clearance after Lung Damage: The Essential Role of MerTK-mediated Alveolar Macrophage Efferocytosis.

Angela Haczku

Open access · hybridAbstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Angela HaczkuSchool of Medicine University of California Davis, California.ORCID 0000-0002-1301-4941
University of California System · US

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
IND enabling development of LGM2605 as adjuvant treatment for asthmaR42AI132012 · NIAID · LIGNAMED, LLC · PI HACZKU, ANGELA, SIELECKI, THAIS MOTRIA · 2019 to 2021
$3.0M
Mechanisms of social-stress enhanced allergic airway response in a mouse modelR01AI072197 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HACZKU, ANGELA · 2010 to 2014
$2.0M
Regulation of Inflammation in Asthma by Fas LigandR01HL076646 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HACZKU, ANGELA · 2005 to 2009
$1.8M
Surfactant-Protein Innate Immunity in an Asthma ModelR01AI055593 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HACZKU, ANGELA · 2004 to 2008
$1.6M
Effects of ozone exposure on expression and function of surfactant protein DRC1ES018505 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI HACZKU, ANGELA · 2009 to 2010
$1.0M
Asthma, anxiety and GR abnormalities in non-human primatesR21AI116121 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HACZKU, ANGELA · 2015 to 2016
$448k
Natural Th17 cells in allergic airway diseaseR21AI105046 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HACZKU, ANGELA, JORDAN, MARTHA S · 2013 to 2014
$440k
Surfactant-Protein Innate Immunity in an Asthma ModelR21AI055593 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HACZKU, ANGELA · 2003 to 2003
$308k
Effects of LGM2605 on a Primate Model of AsthmaR41AI132012 · NIAID · LIGNAMED, LLC · PI HACZKU, ANGELA, SIELECKI, THAIS MOTRIA · 2017 to 2017
$278k
NHLBI NIH HHS R01 HL076646NIAID NIH HHS R01 AI055593NIAID NIH HHS R01 AI072197NIAID NIH HHS R21 AI055593NIAID NIH HHS R21 AI105046NIAID NIH HHS R21 AI116121NIAID NIH HHS R41 AI132012NIAID NIH HHS R42 AI132012NIEHS NIH HHS RC1 ES018505NIH HHS P51 OD011107
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

c-Mer Tyrosine KinaseMacrophages, AlveolarPhagocytosisProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesAnimalsApoptosisEfferocytosisHumansMicec-Mer Tyrosine KinaseMertk protein, mouseProto-Oncogene ProteinsReceptor Protein-Tyrosine Kinases

Identifiers

PMID38502903
PMCPMC11160414
OpenAlexW4392938443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.